✦ LIBER ✦

DNA Methylation status of Wnt antagonistSFRP5can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

✍ Scribed by Jian Zhu, Yuyan Wang, Jianchun Duan, Hua Bai…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New strategies to overcome limitations o

✍ Doebele, Robert C.; Oton, Ana B.; Peled, Nir; Camidge, D. Ross; Bunn, Paul A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 757 KB

The Potential Clinical and Economic Outc

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

First-line therapy and methylation statu

✍ Salazar, Fernanda; Molina, Miguel Angel; Sanchez-Ronco, Maria; Moran, Teresa; Ra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Characterization of skin pathology in no

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Mutations in the tyrosine kinase domain

✍ Rosell, Rafael; Ichinose, Yukito; Taron, Miquel; Sarries, Carme; Queralt, Cristi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 425 KB

Mutation abundance affects the efficacy

✍ Zhao, Ze-Rui; Wang, Jin-Feng; Lin, Yong-Bin; Wang, Fang; Fu, Sha; Zhang, Shu-Lin 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 328 KB